- Human papillomavirus: wearisome or awesome issue?
-
Cho NH
- KMID: 2130110
- J Gynecol Oncol.
- 2014 Oct;25(4):265-266.
- doi: 10.3802/jgo.2014.25.4.265
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Impact of Chlamydia trachomatis and HPV Infection Among Sexually Active Teenage Girls in Upper Silesia, Poland
-
Friedek D, Ekiel A, Romanik M, Chelmicki , Chelmicki , Martirosian G
- KMID: 1712762
- J Korean Med Sci.
- 2005 Aug;20(4):704-705.
- doi: 10.3346/jkms.2005.20.4.704
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of the AdvanSure Human Papillomavirus Screening Real-Time PCR, the Abbott RealTime High Risk Human Papillomavirus Test, and the Hybrid Capture Human Papillomavirus DNA Test for the Detection of Human Papillomavirus
-
Hwang Y, Lee M
- KMID: 1381685
- Ann Lab Med.
- 2012 May;32(3):201-205.
- doi: 10.3343/alm.2012.32.3.201
BACKGROUND: We evaluated the performance of various commercial assays for the molecular detection of human papillomavirus (HPV); the recently developed AdvanSure HPV Screening real-time PCR assay (AdvanSure PCR) and the... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Efficacy of HPV DNA Chip Test in the Era of HPV Vaccination: 1,211 Cases, A Single Institution Study
-
Kahng J, Lee HJ
- KMID: 1781561
- Korean J Lab Med.
- 2008 Feb;28(1):70-78.
- doi: 10.3343/kjlm.2008.28.1.70
BACKGROUND: Human papillomavirus (HPV) prophylactic vaccines, bivalent types for HPV-16/18 with 70% prophylactic expectation, have been developed based on the genotypes found prevalent in the western countries, but little is... -
- CITED
-
- Close
- SHARE
-
- Close
- Prospective comparison of hybrid capture 2 and SPFâ‚â‚€-LiPA for carcinogenic human papillomavirus detection and risk prediction of cervical cancer: a population-based cohort study in China
-
Dong L, Feng RM, Zhang L, Xu XQ, Zhao XL, Wang MZ, Qiao YL, Zhao FH
- KMID: 2413226
- J Gynecol Oncol.
- 2017 Sep;28(5):e66.
- doi: 10.3802/jgo.2017.28.e66
OBJECTIVE: To investigate the extent of the cross-reactivity of hybrid capture 2 (HC2) assay and evaluate the potential effect of cross-reactivity on the long-term risk for cervical cancer and precancers. METHODS:... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Validation of AdvanSure GenoBlot Assay as Primary Screening and Test of Cure for Human Papillomavirus Infection
-
Kahng J, Oh EJ, Lee HN, Lee DW, Kim Y
- KMID: 1791905
- Ann Lab Med.
- 2014 Mar;34(2):127-133.
- doi: 10.3343/alm.2014.34.2.127
BACKGROUND: Clinical specificity and sensitivity are essential factors in the adoption of a human papillomavirus (HPV) test as a primary screening tool and test of cure after treatment of cervical... -
- CITED
-
- Close
- SHARE
-
- Close
- Human Papilloma Virus Genotyping Assay using Restriction Fragment Mass Polymorphism Analysis, and Its Comparison with Sequencing and Hybrid Capture Assays
-
Lee EH, Chung HJ, Oh HB, Chi HS, Jee MS, Park SN, Hong SP, Yoo W, Kim SO
- KMID: 1121662
- Korean J Lab Med.
- 2007 Feb;27(1):62-68.
- doi: 10.3343/kjlm.2007.27.1.62
BACKGROUND: Infection with human papilloma virus (HPV) is the main cause of cervical cancer, and HPV genotyping is of increasing importance for determining clinical course and management of the... -
- CITED
-
- Close
- SHARE
-
- Close
